Study finds link between racial factors and likelihood of getting proven diabetes treatment
Consequences of covid-19 on the childhood obesity epidemic
15 April 2021Visio-vestibular examination is critical part of diagnosing concussion in young athletes
15 April 2021Study finds link between racial factors and likelihood of getting proven diabetes treatment
A new study from researchers at the Perelman School of Medicine at the University of Pennsylvania found significant disparities in the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of drugs proven to treat type 2 diabetes, with usage remaining low with Black, Asian, and lower-income groups despite an increase in overall usage for patients with type 2 diabetes. The study is published in JAMA Network Open.
